With semaglutide accessible from $88 per 30 days and tirzepatide from $158 per month — the two inclusive of clinician support, refills, and the full care suite — WellMedr's benefit proposition is tricky to forget about in a sector where by GLP-1 treatment expenses frequently run multiples higher via